Why I’d Steer Clear of Aurora Cannabis Right Now

Here’s why I wouldn’t touch Aurora Cannabis (TSX:ACB)(NYSE:ACB) right now. There are much better options out there today.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The cannabis market is hot now. Forget that, it’s red-hot at the moment.

Cannabis plays have taken off, though not in sync as they previously have. It appears investors are starting to hand-pick names more than ever before. And unlike some of my other top cannabis picks, Aurora Cannabis (TSX:ACB)(NYSE:ACB) hasn’t done as well as some of its peers in reaching for its 2019 highs.

Here’s why I think that’s the case, and why I’d recommend investors consider other cannabis names right now.

Lackluster earnings continue to disappoint stakeholders

Earnings haven’t really been that important to cannabis plays in recent years. During the run-up in cannabis valuations in 2018 and 2019, revenue growth is all that mattered.

However, of late, investors appear to be more concerned with not only top-line growth. Revenue and earnings quality matters more than ever before.

Accordingly, finding cannabis stocks with a strong financial standing is more important than ever. And on this front, Aurora hasn’t impressed investors.

The company recently posted earnings that missed the mark, as far as investors an analysts are concerned. The company’s revenue of $55 million was down 25% year over year. This comes amid a spike in cannabis sales domestically.

These numbers also greatly missed analyst expectations of $69 million this past quarter. Accordingly, it appears investors are focusing on other cannabis plays, with a greater focus on U.S. MSOs with greater growth potential over the medium- to long-term.

The company did post an adjusted EBITDA of nearly $24 million this past quarter. This was an improvement over last year, albeit the company did post a wider-than-expected loss.

Aurora’s 53% drop in recreational pot sales was disappointing to even the most bearish investors. Accordingly, it’s hard to look on the bright side with this stock right now.

Bottom line

I think the rather bearish note analysts are taking with Aurora right now is warranted. Among the Canadian cannabis sector, I haven’t been bullish on Aurora in the past. I view this company as a tertiary player in a sector with better options.

Accordingly, this is a stock I wouldn’t touch right now.

I think there are much better options from a growth and fundamentals standpoint right now. And with fundamentals finally starting to matter, this is more important than ever for investors to consider.

Investors seeking growth in the cannabis space would be much better-served checking out other high-quality U.S. MSOs right now. My top cannabis pick today is Curaleaf  for this reason.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »